Specialty
Certifications
Pediatric Endocrinology
American Board of Pediatrics
Clinical Focus
- Autoimmune Hypothyroidism
- CHARGE Syndrome
- Children Born Small For Gestational Age
- Congenital Adrenal Hyperplasia
- Congenital Hyperinsulinism
- Congenital Hypothyroidism
- Delayed Puberty
- Graves Disease
- Growth Failure
- Growth Hormone Deficiency
- Hypergonadotropic Hypogonadism
- Hyperparathyroidism
- Hypogonadotropic Hypogonadism
- Hypoparathyroidism
- Idiopathic Short Stature
- Kleinfelter Syndrome
- MEN 1 & 2
- Medication-Induced Diabetes
- Neonatal Graves Disease
- Neurofibromatosis
- Obesity
- Overgrowth
- Polycystic Ovary Syndrome
- Prader-Willi Syndrome
- Precocious Puberty
- Rickets
- Russell-Silver Syndrome
- Turner Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
Education
MD, S.U.N.Y., Health Science Center
Residency, Pediatrics
Long Island Jewish Medical CenterFellowship, Pediatric Endocrinology
St. Christopher's Hosp. for Child.Fellowship, Pediatric Endocrinology
New York Hospital Cornell University Med Ctr
Biography
Robert Rapaport is Professor of Pediatrics and the Director of the Division of Pediatric Endocrinology and Diabetes at Mount Sinai School of Medicine. He is also the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes. Dr. Rapaport received his medical degree from State University of New York - Downstate Medical Center, training in Pediatrics at Schneider's Children's Hospital (Long Island Jewish Hospital - Hillside Medical Center) and his fellowship training in Pediatric Endocrinology at St. Christopher's Hospital for Children, Philadelphia and New York Hospital-Cornell Medical Center, New York. He has published numerous articles and chapters including chapters in major Pediatric (Nelson) and Pediatric Endocrinology (Sperling, Lifshitz and Pescovitz) textbooks. Dr. Rapaport’s current research interests include growth and growth hormone in children born SGA, neonatal thyroid disease, growth hormone-immune interactions, aspects of childhood diabetes and pubertal disorders.
Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rapaport during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Novo Nordisk
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Eli Lilly and Company
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
1468 Madison Avenueth 4th Floor Suite 4-81
New York, NY 10029
- Monday 1:00pm - 5:00pm
- Tuesday 2:00pm - 5:00pm
- Wednesday 1:00pm - 5:00pm
- Thursday 1:00pm - 5:00pm
- Friday 1:00pm - 5:00pm
- Aetna U.S. Healthcare
- Blue Shield of New Jersey
- CHUBB Health
- Empire Blue Cross/Blue Shield
- Medicaid
- Medicare
- Medicare Assignment
- Other
- Oxford Health Plans
- PHS/Healthnet/Guardian
- Prudential Healthcare: a member company of Aetna
- United Healthcare